Why is Natraj Proteins Ltd falling/rising?

Recent Price Performance and Market Context

The stock has demonstrated resilience in the short term, outperforming the broader Sensex and its sector peers. Over the past week, Natraj Proteins gained 2.68%, significantly ahead of the Sensex’s modest 0.16% rise. The one-month return of 3.50% contrasts sharply with the Sensex’s decline of 4.78%, while year-to-date the stock has managed a slight gain of 0.59% against the benchmark’s 4.17% fall. This recent momentum is further underscored by a three-day consecutive gain, during which the stock appreciated by 9.56%.

On the day in question, the stock opened with a strong gap up of 13.72%, reaching an intraday high of ₹35.40. The trading session was marked by high volatility, with an intraday price range of ₹4.40 and a volatility measure of 6.63%. Despite this, the weighted average price indicated that a larger volume of shares traded closer to the lower end of the day’s range, suggesting some profit-taking or cautious positioning by investors. The stock’s price remains above its 5-day and 20-day moving averages but continues to lag behind longer-term averages such as the 50-day, 100-day, and 200-day, signalling a mixed technical outlook.

Valuation and Profitability Considerations

From a valuation standpoint, Natraj Proteins appears attractively priced. The company’s return on capital employed (ROCE) stands at 1%, and it trades at an enterprise value to capital employed ratio of 0.7, indicating a discount relative to its peers’ historical averages. This valuation appeal may be enticing investors seeking value opportunities in a market where many stocks are trading at stretched multiples.

Moreover, despite the stock’s negative total return of 29.10% over the past year, the company’s profits have increased by 55.3% during the same period. This divergence between profit growth and share price performance suggests that the market may be cautiously optimistic about the company’s earnings potential, even as it weighs other risks.

However, the company’s profitability metrics remain subdued. The average return on equity (ROE) is a modest 6.97%, reflecting limited profitability relative to shareholders’ funds. Additionally, the company has reported operating losses, which undermine its long-term fundamental strength. The latest quarterly results for September 2025 reveal a contraction in net sales by 23.59% to ₹76.54 crores over nine months, alongside a negative PBDIT of ₹-1.02 crores and an operating profit margin of -3.79%. These figures highlight ongoing operational challenges that may temper investor enthusiasm.

Trading Activity and Investor Participation

Investor participation has shown signs of waning, with delivery volumes on 01 February plunging by 91.7% compared to the five-day average. This decline in committed buying interest could indicate that the recent price gains are driven more by short-term speculative trading rather than sustained institutional accumulation. Despite this, the stock remains sufficiently liquid for sizeable trades, which supports continued market activity.

It is also noteworthy that the majority shareholders are non-institutional, which may influence the stock’s trading dynamics and volatility. The stock’s consistent underperformance relative to the BSE500 index over the past three years, with a cumulative loss of 39.66% compared to the benchmark’s 36.26% gain, underscores the challenges faced by the company in delivering shareholder value over the longer term.

Conclusion: Why the Stock Is Rising Despite Challenges

The recent rise in Natraj Proteins Ltd’s share price on 02 February can be attributed primarily to short-term market momentum and valuation-driven interest. The stock’s outperformance relative to the Sensex and sector peers, coupled with a strong opening gap and three consecutive days of gains, reflects positive sentiment among traders and some investors attracted by the company’s discounted valuation metrics.

Nonetheless, the company’s weak long-term fundamentals, including operating losses, declining sales, and low profitability ratios, continue to weigh on investor confidence. The subdued delivery volumes and high intraday volatility suggest that the rally may be fragile and susceptible to reversal if operational performance does not improve or if broader market conditions deteriorate.

Investors should therefore approach Natraj Proteins with caution, balancing the appeal of its current price momentum and valuation against the risks posed by its financial and operational challenges. Monitoring upcoming quarterly results and changes in investor participation will be crucial to assessing whether the recent gains can be sustained over the medium to long term.

Get 2 full years of MojoOne Premium for only Rs. 12,999. Subscribe for 1 year and we'll add another year FREE. Offer valid for a limited time. Start Saving Now →